Make the smart choice and register for this webinar!
Critical starting materials such as plasmid DNA make a world of difference when it comes to cell and gene therapy, regenerative medicine and vaccine development. This Endpoints Webinar will focus on how you need the right manufacturing partner to support long-term clinical success. Join Aldevron's Matthew Howard and Tyler Kozisek on May 2! Register today! https://lnkd.in/gmV_x8vY
Check out this on-demand webinar on long-term follow-up (LFTU) considerations for cell and gene therapy studies featuring our colleagues from Thermo Fisher Scientific as well as industry experts.
Our Development Head of Cell and Gene Therapy, Carolyn Sasse, recently shared her predictions on #clinicaltrial trends for the #biopharma industry in 2024 as part of Citeline’s #ScripAsks series. Explore Carolyn’s perspectives on the importance of patient centricity in clinical trials: https://bit.ly/42uY7Ae
Only one week until our 'Overcoming Challenges in the Industrialisation of iPSC-derived therapies' webinar! Cell and Gene Therapy Catapult's Márcia F. Mata, will be discussing examples of how we are working to address key manufacturing challenges within the allogeneic cell therapy field; developing scalable, automated, and controlled processes to help bring these pioneering advanced therapies to patients will be discussed. Register now: https://buff.ly/3y9Z5XJ #iPSC #AdvancedTherapies #CellTherapies #GeneTherapies
It was an absolute pleasure to attend and speak at the Gene Therapy Patient Engagement Summit again last week! A few takeaways: 📩 Direct and indirect engagement with the patient community should start even before the pre-clinical phase, as soon as a target condition has been identified 🤝 Early internal cross-functional alignment is critical to ensure patient advocacy is integrated into and considered in every functions' outputs 🏥 More consideration is needed when communicating the commitment of the long-term follow-up required post-gene therapy trials; for patients who have lived around hospital appointments and procedures for decades, we cannot underestimate the burden of having to continue this for a further 15 years 📺 When planning engagements and outreach to patients, it is critical to meet the communities where they're at
Thank you to everyone who joined Isabelle Blomfield and Lauren Coleman-Bennett's presentation on "The importance of early patient engagement in cell and gene therapy development" at the Gene Therapy Patient Engagement Summit last week. We hope you found the session interesting! If you missed it, keep an eye out for the presentation recording coming soon... To learn more about the support we can offer in gathering and using patient insights with maximum impact, get in touch at contact@amiculum.biz #GeneTherapy #PatientEngagement #PatientInsights
Heading to RESI / JPM conference today. If you want to hear how Opsin Biotherapeutics, Inc. is addressing the chronic pain epidemic using our disruptive neuromodulation therapy using gene therapy and light, reach out and we can set up a time to meet! #chronicpain #neuromodulation #spinalcordstimulation
Dr. Paolo Siciliano, Martin Sowden, Shanton Wilcox, and Harry Ustik, my colleagues at PA Consulting wrote a thought-provoking piece on the intricacies of manufacturing in the cell and gene therapy space for SupplyChainBrain. #GeneTherapy #MedicalManufacturingChallenges #AutologousCommercialCellTherapy
From cell and gene therapy development to every day lab techniques, transfection is a technique many of us know well. But transfection methods vary and are suited to different applications. Explore the various methods and their unique quirks in our latest In Focus feature with Sartorius! Whether you're working with DNA or mRNA, we've got you covered with essential tips. >>> https://hubs.ly/Q02MkThj0
Let's connect at #ISCT2024! Join our panel discussion on current state and future directions of process analytical technologies. We're elevating your process with cell collections, cell expansion, and fill-finish. Looking forward to seeing you there. #CellandGeneTherapy #CGT ISCT, International Society for Cell & Gene Therapy
🚀 Counting down the days to the Terrapinn #advancedtherapies Congress on 19-20 March in London! 📆 Looking forward to meeting cell and gene therapy experts! By the way - mates special rates expire on 23rd February! #cellandgenetherapy #cellandgenetherapies #futureofmedicine
The Cell and Gene Therapy Catapult Annual Review details the UK ATMP industry growth and CGT Catapult impact. It also highlights the the four conditions that need to be met for the continued growth and success of the industry. Download it here - https://ow.ly/WVKr50ThbgA
